Selection of optimal first-line immuno-related therapy based on specific pathological characteristics for patients with advanced driver-gene wild-type non-small cell lung cancer: a systematic review and network meta-analysis

BACKGROUND: Although immune checkpoint inhibitors (ICIs) have improved survival for advanced wild-type non-small cell lung cancer (NSCLC), a lack of direct comparisons of various first-line treatments is clouding clinical decision-making. A network meta-analysis was conducted to compare current firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Lei, Gao, Jing, Xu, Qian, Zhang, Xue, Huang, Miao, Dai, Xin, Li, Song, Liu, Lian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165528/
https://www.ncbi.nlm.nih.gov/pubmed/34104227
http://dx.doi.org/10.1177/17588359211018537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165528/
https://www.ncbi.nlm.nih.gov/pubmed/34104227
http://dx.doi.org/10.1177/17588359211018537

Ejemplares similares